Drug Type Fusion protein |
Synonyms- |
Target |
Action modulators |
Mechanism C3d modulators(C3d modulators), CR1 modulators(complement C3b/C4b receptor 1 (Knops blood group) modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Eye Diseases | Preclinical | United States | 13 Feb 2025 |